Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Fractures, Spontaneou"'
Autor:
Matteo Cadossi, Luca Cevolani, Davide Maria Donati, Francesca de Terlizzi, Giuseppe Bianchi, Enrico Bonicoli, Giovanni Ciani, Francesco Benazzo, Leo Massari, François Cornelis, Daniele Screpis, Mario Mosconi, Costantino Errani, Barbara Rossi, Flavio Fazioli, Michele Boffano, Andrea Tognù, M. Nicolosi, Paolo Spinnato, Laura Campanacci, Giancarlo Facchini, Raimondo Piana
Publikováno v:
European Journal of Surgical Oncology. 47:2609-2617
Introduction Bone metastases are frequent in patients with cancer. Electrochemotherapy (ECT) is a minimally invasive treatment. Preclinical and clinical studies supported the use of ECT in patients with metastatic bone disease (MBD). The purposes of
Autor:
Giuseppe, Basile, Franco Maria, Avato, Alberto, Passeri, Riccardo, Accetta, Federico, Amadei, Arianna, Giorgetti, Daniele, Castoldi, Stefania, Fozzato
Humeral shaft fractures account for 1- 3% of all fractures and about 20-27% of those involving the humerus. In the past they were often conservatively treated, with an acceptable consolidation rate. Open reduction and internal fixation (ORIF) is the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::94ab3faa07d1ce46a231e9c167c1ade8
https://hdl.handle.net/11585/903639
https://hdl.handle.net/11585/903639
Autor:
Akira Kido, Alberto Righi, Costantino Errani, Manabu Akahane, Giulio Leone, Kanya Honoki, Andreas F. Mavrogenis, Davide Maria Donati, Yasuhito Tanaka, Shinji Tsukamoto, Piergiuseppe Tanzi
Publikováno v:
Journal of surgical oncology. 119(7)
Background There are conflicting reports for the outcome of the patients with giant cell tumor of bone (GCTB) and pathological fracture at presentation treated with curettage or resection. This study compared local recurrence, complications, and func
Autor:
Stefano Palomba, Achille Tolino, Francesco Manguso, Angela Sacchinelli, Francesco Orio, Pasquale Mastrantonio, Fulvio Zullo, Tiziana Russo, Rosamaria Oppedisano, Angela Falbo
Objective: To evaluate long-term efficacy of risedronate in osteoporotic postmenopausal patients with inflammatory bowel disease (IBD). Design: A prospective, parallel, open-label, 2-year extension study of a randomized, double-blind, 1-year clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::061c351aba9dcb3039b2c082d2402220
http://hdl.handle.net/11588/720427
http://hdl.handle.net/11588/720427